Circulating 25-hydroxyvitamin D Levels and Frailty Status in Older Women
Overview
Authors
Affiliations
Context: Vitamin D deficiency and frailty are common with aging, but the association between these conditions is uncertain.
Objective: To determine the association between 25-hydroxyvitamin D (25(OH)D) levels and prevalent and incident frailty status among older women.
Design: Cross-sectional and longitudinal analyses of a prospective cohort study.
Setting: Four U.S. centers.
Participants: 6307 women aged≥69 years.
Main Outcome Measures: Frailty status classified as robust, intermediate stage, or frail at baseline; and robust, intermediate stage, frail, or dead (all-cause mortality) at follow-up an average of 4.5 years later.
Results: At baseline, there was a U-shaped association between 25(OH)D level and odds of frailty with the lowest risk among women with levels 20.0-29.9 ng/ml (referent group). Compared with this group, the odds of frailty were higher among those with levels<15.0 ng/ml [multivariable odds ratio (MOR) 1.47, 95% confidence interval (CI), 1.19-1.82], those with levels 15.0-19.9 ng/ml (MOR 1.24, 95% CI 0.99-1.54), and those with levels≥30 ng/ml (MOR 1.32, 95% CI 1.06-1.63). Among 4551 nonfrail women at baseline, the odds of frailty/death (vs. robust/intermediate) at follow-up appeared higher among those with levels 15.0-19.9 ng/ml (MOR 1.21, 95% CI 0.99-1.49), but the CI overlapped 1.0. The odds of death (vs. robust/intermediate/frail at follow-up) was higher among those with levels<15.0 ng/ml (MOR 1.40, 95% CI 1.04-1.88) and those with levels 15.0-19.9 ng/ml (MOR 1.30, 95% CI 0.97-1.75), although the latter association did not quite reach significance.
Conclusion: Lower (<20 ng/ml) and higher (≥30 ng/ml) levels of 25(OH)D among older women were moderately associated with a higher odds of frailty at baseline. Among nonfrail women at baseline, lower levels (<20 ng/ml) were modestly associated with an increased risk of incident frailty or death at follow-up.
Vitamin D supplementation: Biochemical and inflammatory effects in non-pathological Wistar rats.
Muller de Moura Sarmento S, Gomes Schmitt E, Smolski Dos Santos L, Erminda Schreiner G, Tamborena Malheiros R, Klock C Toxicol Rep. 2025; 14:101901.
PMID: 39897401 PMC: 11786669. DOI: 10.1016/j.toxrep.2025.101901.
Duchesneau E, Shmuel S, Faurot K, Musty A, Park J, Sturmer T PLoS One. 2023; 18(6):e0286984.
PMID: 37289795 PMC: 10249888. DOI: 10.1371/journal.pone.0286984.
An Integrated Approach to Skeletal Muscle Health in Aging.
Agostini D, Gervasi M, Ferrini F, Bartolacci A, Stranieri A, Piccoli G Nutrients. 2023; 15(8).
PMID: 37111021 PMC: 10141535. DOI: 10.3390/nu15081802.
Frailty, gaps in care coordination, and preventable adverse events.
Akinyelure O, Colvin C, Sterling M, Safford M, Muntner P, Colantonio L BMC Geriatr. 2022; 22(1):476.
PMID: 35655193 PMC: 9164877. DOI: 10.1186/s12877-022-03164-7.
Dai M, Yue J, Zhang J, Wang H, Wu C BMC Geriatr. 2022; 22(1):159.
PMID: 35220949 PMC: 8883641. DOI: 10.1186/s12877-022-02857-3.